MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$13,305K
Foreign currency
translation adjustments
$125K
Unrealized gain (loss) on
available-for-sale securities
$12K
Net loss
-$13,442K
Income tax benefit
(expense)
-$46K
Net loss before
income tax expense
-$13,488K
Interest income
$300K
Fair value
adjustment for warrants
-$291K
Loss from operations
-$13,430K
Fair value
adjustment for debt
$549K
Other income
(expense), net
-$58K
Warrant issuance costs
$42K
Total operating
expenses
$13,430K
Research and development
$8,083K
General and
administrative
$3,281K
Fair value
adjustment for contingent...
$2,066K
Back
Back
Income Statement
source: myfinsight.com
Quince Therapeutics, Inc. (QNCX)
Quince Therapeutics, Inc. (QNCX)